Ugrás a tartalomra
Merck
Összes fotó(1)

Fontos dokumentumok

View All Documentation

C2175000

Cimetidine

European Pharmacopoeia (EP) Reference Standard

Szinonimák:

SKF-92334

Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez
Összes fotó(1)

About This Item

Tapasztalati képlet (Hill-képlet):
C10H16N6S
CAS-szám:
51481-61-9
Molekulatömeg:
252.34
MDL-szám:
MFCD00133296
UNSPSC kód:
41116107
PubChem Substance ID:
329774972
NACRES:
NA.24

grade

pharmaceutical primary standard

API-család

cimetidine

gyártó/kereskedő neve

EDQM

alkalmazás(ok)

pharmaceutical (small molecule)

Formátum

neat

tárolási hőmérséklet

2-8°C

SMILES string

CN\C(NC#N)=N\CCSCc1nc[nH]c1C

InChI

1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)

Nemzetközi kémiai azonosító kulcs

AQIXAKUUQRKLND-UHFFFAOYSA-N

Géninformáció

human ... HRH2(3274)

Looking for similar products? Látogasson el ide Útmutató a termékösszehasonlításhoz

Általános leírás

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Alkalmazás

Cimetidine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Kiszerelés

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Egyéb megjegyzések

Sales restrictions may apply.

kapcsolódó termék

Product No.
Leírás
Árazás

PHR1089

Cimetidine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

1134073

Cimetidine hydrochloride, United States Pharmacopeia (USP) Reference Standard

C2175500

Cimetidine hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0001130

Cimetidine for peak identification, European Pharmacopoeia (EP) Reference Standard

Y0001146

Cimetidine for system suitability, European Pharmacopoeia (EP) Reference Standard

1134062

Cimetidine, United States Pharmacopeia (USP) Reference Standard

BP475

Cimetidine, British Pharmacopoeia (BP) Reference Standard

PHR2242

Cimetidine Impurity D, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2220

Cimetidine Impurity A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2250

Cimetidine Impurity B, pharmaceutical secondary standard, certified reference material

PHR2251

Cimetidine Impurity C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2252

Cimetidine Impurity J, certified reference material, pharmaceutical secondary standard

PHR2259

Cimetidine Impurity G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2260

Cimetidine Impurity I, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2255

Cimetidine Impurity H

PHR2243

Cimetidine Impurity E, Pharmaceutical Secondary Standard; Certified Reference Material

Tárolási osztály kódja

11 - Combustible Solids

WGK

WGK 3

Válasszon a legfrissebb verziók közül:

Analitikai tanúsítványok (COA)

Lot/Batch Number

Sajnos jelenleg COA nem áll rendelkezésre ehhez a termékhez online.

Ha segítségre van szüksége, lépjen velünk kapcsolatba Vevőszolgálat

Már rendelkezik ezzel a termékkel?

Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.

Dokumentumtár megtekintése

Martina Kubecova et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 42(5), 439-444 (2011-02-19)
Cimetidine, H(2) receptor antagonists, is commonly prescribed for gastric and duodenal ulcer disease. Additionally, cimetidine has been shown to have anticancer effects. This review describes the mechanism of antitumor action of cimetidine including its ability to interfere with tumor cell
Florence Lefranc et al.
International journal of oncology, 28(5), 1021-1030 (2006-04-06)
Cimetidine (CIM), the prototypical histamine H2 receptor antagonist (H2RA), was brought to market based on its ability to accelerate healing of gastrointestinal ulcers through the inhibition of gastric acid secretion. Cimetidine, the most studied H2RA, has been demonstrated to possess
P San Miguel et al.
Virchows Archiv : an international journal of pathology, 430(3), 261-263 (1997-03-01)
A case of carcinoma in the breast of a male patient with a chronic gastric ulcer is described. The patient had received cimetidine for 17 years. Histological examination of an excisional biopsy showed lobular in situ and infiltrating carcinoma. In
J P Harcourt et al.
International journal of pediatric otorhinolaryngology, 51(2), 109-113 (2000-01-05)
Effective adjuvant treatment for recurrent respiratory papillomatosis (RRP) is at present limited to alpha-interferon, which may have significant side effects including rebound growth of papillomata following its withdrawal, is given by injection and is expensive. High dose cimetidine is known
A Kumar
DICP : the annals of pharmacotherapy, 24(3), 289-295 (1990-03-01)
Suppressor T lymphocytes possess histamine2 (H2) receptors and contribute significantly to the function of the immune system. Experimentally, cimetidine, an H2-receptor antagonist, has been shown to enhance a variety of immunologic functions both in vivo and in vitro because of
View All Related Papers

Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.

Lépjen kapcsolatba a szaktanácsadással